Asking the right questions is essential for lowering treatment costs and improving patient outcomes. Initial challenges include navigating regulatory hurdles in research protocols. Retrospective studies offer insights that can refine clinical practices. The emphasis is on developing cost-effective treatments accessible to patients in resource-limited settings. Recent guideline changes highlight the significance of molecular testing in treatment decisions, emphasising the need for ongoing adaptation in clinical practices.